Eye News and Research

Latest Eye News and Research

GOP continues attack on Planned Parenthood, abortion funding

Abortion-rights advocates and abortion-rights opponents don't see eye to eye on much, but they do agree on this: Nobody hates Planned Parenthood quite as much as Mike Pence. The Indiana Republican is on a one-man crusade to deny all federal funding to the group — not just the money it gets for reproductive health and family planning services, but every penny it gets for anything (Kliff, 2/16).

17 Feb 2011

Inexpensive drug therapy shows promise in treating premature infants with childhood blindness

A readily available, inexpensive drug therapy showed a significant benefit in treating premature infants with the worst and historically most difficult-to-treat cases of retinopathy of prematurity.

17 Feb 2011

Assessment of child's learning strategies can reveal signs of vision problems

Parents across Ontario will be soon receiving the second round of newly formatted report cards emphasizing the importance of how students work and how this contributes to their overall academic success. As parents and teachers review each child's progress they may want to consider whether vision problems might be a contributing factor to performance and behaviour in class.

16 Feb 2011

Obesity associated with decreased risk of open-angle glaucoma in women, not men

Obesity may be associated with higher eye pressure and a decreased risk of open-angle glaucoma in women but not men, according to a report posted online today that will appear in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

14 Feb 2011

OXiGENE, NCI/CTEP and GOG collaborate on ZYBRESTAT Phase 2 study in relapsed ovarian cancer

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.

14 Feb 2011

Phase III RISE study of Lucentis for DME meets primary endpoint

Genentech, Inc., a member of the Roche Group, announced today that one of two Phase III studies evaluating monthly Lucentis® (ranibizumab injection) in patients with diabetic macular edema (DME), met its primary endpoint. DME is a serious complication of diabetes that affects up to 10 percent of people with the disease and can lead to blurred vision, severe vision loss and blindness.

14 Feb 2011

New clinical trial to test surgery specifically for Type 2 diabetes

A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.

14 Feb 2011

New trial tests surgery for Type 2 diabetes

11 Feb 2011

EHSI applauds promising new stem cell treatment for Parkinson's

Emerging Healthcare Solutions, Inc. applauded a new study today revealing a promising new stem cell treatment for Parkinson's.

10 Feb 2011

QLT's Phase II olopatadine punctal plug delivery system trial demonstrates safety in allergic conjunctivitis patients

QLT Inc. today announced results from a Phase II proof-of-concept clinical trial for the olopatadine punctal plug delivery system (O‑PPDS).

9 Feb 2011

New study shows eggs are 14% lower in cholesterol

According to new nutrition data from the United States Department of Agriculture's Agricultural Research Service, eggs are lower in cholesterol than previously thought.

8 Feb 2011

New insight into AMD related blindness

more than 50 million worldwideA new study in the journal Nature has reported the pathology of blindness caused by age-related macular degeneration or AMD. This condition affects more than 50 million worldwide and is incurable. The researchers report that when an enzyme known as DICER1 stops functioning AMD starts to develop.

8 Feb 2011

Researchers discover molecular mechanism implicated in geographic atrophy

A team of researchers, led by University of Kentucky ophthalmologist Dr. Jayakrishna Ambati, has discovered a molecular mechanism implicated in geographic atrophy, the major cause of untreatable blindness in the industrialized world.

6 Feb 2011

Transitions Optical unveils golf video tips to raise awareness about healthy vision, sports performance

Transitions Optical, today announced it will unveil the first of a year-long series of golf video tips from PGA TOUR players and professional trainers as part of its "Improve Your Vision, Improve Your Game Video Series."

5 Feb 2011

Vascular birthmarks can cause concern for parents: Dermatologists

Vascular birthmarks, which occur in nearly 10 percent of all infants at birth or within the first few weeks of life, can cause concern for parents particularly if they are large or in a cosmetically important area. The decision to treat a birthmark is one that parents should make with a dermatologist, who can determine the type of birthmark and whether or not it poses any potential risks in the future.

5 Feb 2011

CDC: One quarter of all ED visits during winter are due to snowboarding, sledding accidents

Broken bones due to snowboarding and sledding top the list of common causes for visits to the Emergency Department during the winter months. According to the Centers for Disease Control one quarter of all ED visits are attributed to snowboarding accidents,, and half of all cases were broken bones and sprains.

5 Feb 2011

CVVS scientist receives top UK award for ground-breaking research on vascular stem cells, eye disease

One of Northern Ireland's leading scientists has received a top UK award, to support ground-breaking research into vascular stem cells and eye disease at Queen's University.

5 Feb 2011

Proper skin care, cosmetics can improve skin of acne and rosacea patients

Patients with acne and rosacea are often confused about selecting appropriate skin care products, cosmeceuticals and cosmetics to add into their daily routine. While they want to continue to see results with the treatment regimen from their dermatologist, they also want to be comfortable using products that address other skin issues, such as wrinkles or that protect their skin, such as sunscreens.

5 Feb 2011

Tips for women to ensure a healthy heart and a healthy vacation

Henrico County based Mondial Assistance, the largest travel insurance provider in the world, and the American Heart Association's (AHA) Mid-Atlantic chapter are teaming up for the 2011 Go Red for Women campaign and as part of the effort are offering these tips for women to ensure a healthy heart and a healthy vacation in 2011. Mondial Assistance is a "Healthy Lifestyle" Partner for this year's campaign.

5 Feb 2011

Doctors of Optometry troubled by disregard for vision and eye health needs of children

The American Optometric Association, the voice of America's family eye doctors, today warned that if a set of U.S. Preventive Services Task Force recommendations are adopted as policy, significant harm will be caused to the ongoing efforts of eye doctors nationwide to reverse the high rates of preventable vision loss in children across America, from the first year of life through age 5.

5 Feb 2011